158 related articles for article (PubMed ID: 12971448)
1. Cessation of steroids in stable renal transplant patients: the Leuven experience.
Maes BD; Claes K; Coosemans W; Evenpoel P; Kuypers D; Pirenne J; Vanrenterghem Y
Clin Transpl; 2002; ():181-9. PubMed ID: 12971448
[TBL] [Abstract][Full Text] [Related]
2. Successful steroid withdrawal after long-term administration in renal transplant patients.
Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
[TBL] [Abstract][Full Text] [Related]
3. Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation.
Harada H; Miura M; Ogawa Y; Seki T; Taniguchi A; Takenouchi T; Togashi M; Hirano T
Clin Transplant; 2006; 20 Suppl 15():26-32. PubMed ID: 16848872
[TBL] [Abstract][Full Text] [Related]
4. Benefits derivated from late steroid withdrawal in renal transplant recipients.
Gavela E; Avila A; Sancho A; Kanter J; Beltrán S; Crespo JF; Pallardó LM
Transplant Proc; 2007 Sep; 39(7):2173-5. PubMed ID: 17889128
[TBL] [Abstract][Full Text] [Related]
5. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
6. Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications.
Miozzari M; Ambühl PM
Nephrol Dial Transplant; 2004 Oct; 19(10):2615-21. PubMed ID: 15280521
[TBL] [Abstract][Full Text] [Related]
7. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
Roberti I; Reisman L; Lieberman KV; Burrows L
Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin at six years can exhibit normal renal function without proteinuria or neoplasia after renal transplantation. A single-center experience.
Nungaray N; Arriola M; Gutierrez MJ; Oliva E; Hernández E; Gonzalez E; Andres A; Morales JM
Transplant Proc; 2005 Nov; 37(9):3727-8. PubMed ID: 16386519
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM
Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
[TBL] [Abstract][Full Text] [Related]
13. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
Arora S; Marcus RJ; Dikkala S; Sureshkumar KK
Exp Clin Transplant; 2009 Dec; 7(4):233-6. PubMed ID: 20353373
[TBL] [Abstract][Full Text] [Related]
14. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection.
Oettl T; Zuliani E; Gaspert A; Hopfer H; Dickenmann M; Fehr T
Transplantation; 2010 Mar; 89(6):702-6. PubMed ID: 20010328
[TBL] [Abstract][Full Text] [Related]
15. A multi-factor analysis of kidney regraft outcomes.
Gjertson DW
Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
[TBL] [Abstract][Full Text] [Related]
16. Renal retransplantation: a retrospective monocentric study.
Ott U; Busch M; Steiner T; Schubert J; Wolf G
Transplant Proc; 2008 Jun; 40(5):1345-8. PubMed ID: 18589102
[TBL] [Abstract][Full Text] [Related]
17. Ten years of treatment with tacrolimus is related to an excellent renal function, allowing monotherapy in a large proportion of cases: unicentric results of the tacrolimus versus cyclosporine A European Multicentric Study in kidney transplant patients.
Morales JM; Andrés A; Dominguez-Gil B; Arriola M; Gutiérrez MJ; Hernández E; Ortuño T; Praga M
Transplant Proc; 2005 Nov; 37(9):3738-42. PubMed ID: 16386523
[TBL] [Abstract][Full Text] [Related]
18. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
[TBL] [Abstract][Full Text] [Related]
20. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
